Fior Markets launched a study titled “3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material,Application, Regions”,and Global Forecast 2018-2025

The global 3D bioprinting market is expected to grow from USD 834.21 Million in 2017 to USD 4,320.36 Million by 2025, at a CAGR of 22.82% during the forecast period from 2018-2025. Growing application of 3D printing in the drug discovery, and rise in public and private investment on the research and development activities are driving the market.


Microextrusion 3D bioprinting segment had a market value of USD 353.53 million in 2017

Technology segment is divided into microextrusion, inkjet, laser and magnetic 3D bioprinting. On account of being cost effective fabrication process microextrusion 3D bioprinting segment emerged as the leader in the global 3D bioprinting market with USD 353.53 million revenue in 2017. Inkjet 3D bioprinting segment is also expected to attain a significant market share owing to its compatibility with living cells. Owing to its enhanced speed and precision the magnetic 3D bioprinting segment is projected to grow at the highest CAGR of 24.78% over the forecast period.

Hydrogels segment is anticipated to grow at a CAGR of 24.16% in 2018-2025

Material is segmented into extracellular matrices, hydrogels, living cells, and others.Increasing utilization of living cells in repairing the damaged tissues coupled with their compatibility with biomaterials to repair the damaged microstructures were the factors that led living cells segment to dominate the global 3D bioprinting market with USD 297.89 million revenue in 2017.

Research application segment had a market value of USD 563.84 million in 2017

Application segment is categorized into clinical application and research applications. Factors such as increased financial support from private and public entities for the 3D bioprinting research and development activities propelled research application segment to emerge as the leader with USD 564.84 million revenue in 2017. Research segment is further divided into drug research, regenerative medicine, and 3D cell culture.Clinical application segment is subdivided into skin, bone & cartilage, and blood vessels.


Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. Presence of well-established research institutions and sophisticated healthcare facilities as well as rising adoption of new techniques were the factors that led North America region to lead the global 3D bioprinting market with USD 347.28 million revenue in 2017.

Competitive Analysis:

Major players in the global 3D bioprinting market are Organovo Holdings Inc., EnvisionTEC GmbH, Nano3D Biosciences, Inc., Cyfuse Biomedical K.K., BioBots, Aspect Biosystems Ltd., 3Dynamic Systems Ltd., regenHU Ltd, Cellink, RegenovoBiotechnology Co., Ltd, Poietis, GeSiM, Luxexcel Group B.V., TeVido BioDevices, LLC, Stratasys Ltd, Voxeljet A.G., Materialise N.V. Solidscape, Inc., and among others.

Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team (, who will ensure that you get a report that suits your needs.